Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1) 2019-03-18 20:45
Adlai Nortye's Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC 2019-03-15 17:06
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing 2019-03-12 07:00
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights 2019-03-09 03:57
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 2019-03-07 06:00
China Jo-Jo Drugstores Releases 2019 Letter from the Chairman 2019-03-04 21:00
AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals 2019-03-04 14:00
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA 2019-03-01 18:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results 2019-02-25 21:00
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer 2019-02-21 18:30
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients 2019-02-18 10:08
Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Nine Months Ended December 31, 2018 2019-02-15 05:15
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States 2019-02-13 20:30
GC Pharma Reports Full Year 2018 Results 2019-02-12 22:00
Bridge Biotherapeutics Presented Preclinical and Phase I Study Results for BBT-401 at the Crohn's & Colitis Congress 2019-02-11 22:00
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies 2019-02-11 20:18
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare 2019-02-11 18:30
1 132 133 134 135 136 165